| Dr Simon Elliot Prince, DO | |
|
1129 Northern Blvd, Ste 101, Manhasset, NY 11030-3045 | |
| (516) 365-5570 | |
| (516) 365-5532 |
| Full Name | Dr Simon Elliot Prince |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 27 Years |
| Location | 1129 Northern Blvd, Manhasset, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770589285 | NPI | - | NPPES |
| 02256797 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 223647 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Queens-long Island Renal Institute | New hyde park, NY | Dialysis facility |
| North Shore University Hospital | Manhasset, NY | Hospital |
| St Francis Hospital - The Heart Center | Roslyn, NY | Hospital |
| Long Island Jewish Medical Center | New hyde park, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prine Health Medical Group, Pllc | 1557600384 | 62 |
News Archive
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
New research by a Baylor University professor shows that licensed clinical social workers (LCSWs), who account for the largest number of clinically trained helping professionals, believe that discussions about their clients' religion and spirituality can often lead to improved health and mental health, but practitioners are not integrating these conversations into their counseling sessions.
EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.
Why do we almost instinctively treat babies as special, protecting them and enabling them to survive? Darwin originally pointed out that there is something about infants which prompts adults to respond to and care for them which allows our species to survive.
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
› Verified 3 days ago
| Entity Name | North Shore Nephrology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861413718 PECOS PAC ID: 5496645632 Enrollment ID: O20040319000353 |
News Archive
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
New research by a Baylor University professor shows that licensed clinical social workers (LCSWs), who account for the largest number of clinically trained helping professionals, believe that discussions about their clients' religion and spirituality can often lead to improved health and mental health, but practitioners are not integrating these conversations into their counseling sessions.
EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.
Why do we almost instinctively treat babies as special, protecting them and enabling them to survive? Darwin originally pointed out that there is something about infants which prompts adults to respond to and care for them which allows our species to survive.
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
› Verified 3 days ago
| Entity Name | Prine Health Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144790163 PECOS PAC ID: 1557600384 Enrollment ID: O20190222000152 |
News Archive
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
New research by a Baylor University professor shows that licensed clinical social workers (LCSWs), who account for the largest number of clinically trained helping professionals, believe that discussions about their clients' religion and spirituality can often lead to improved health and mental health, but practitioners are not integrating these conversations into their counseling sessions.
EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.
Why do we almost instinctively treat babies as special, protecting them and enabling them to survive? Darwin originally pointed out that there is something about infants which prompts adults to respond to and care for them which allows our species to survive.
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Simon Elliot Prince, DO 1129 Northern Blvd, Ste 101, Manhasset, NY 11030-3045 Ph: (516) 365-5570 | Dr Simon Elliot Prince, DO 1129 Northern Blvd, Ste 101, Manhasset, NY 11030-3045 Ph: (516) 365-5570 |
News Archive
Fitch Ratings has assigned a 'AA' rating to the expected issuance of approximately $225 million of Indiana Finance Authority Health System revenue bonds, series 2009A (Sisters of St. Francis Health Services, Inc. Obligated Group; (SSFHS). In addition, Fitch affirms the outstanding 'AA' long-term ratings on approximately $950.3 million of bonds issued for SSFHS.
New research by a Baylor University professor shows that licensed clinical social workers (LCSWs), who account for the largest number of clinically trained helping professionals, believe that discussions about their clients' religion and spirituality can often lead to improved health and mental health, but practitioners are not integrating these conversations into their counseling sessions.
EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.
Why do we almost instinctively treat babies as special, protecting them and enabling them to survive? Darwin originally pointed out that there is something about infants which prompts adults to respond to and care for them which allows our species to survive.
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
› Verified 3 days ago
Samit Shah, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-1427 | |
William J Berger, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1201 Northern Blvd Ste 201, Manhasset, NY 11030 Phone: 516-488-4428 Fax: 516-328-2723 | |
Lawrence Ong, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Nsuh Dept Of Medicine Cardiology, 300 Community Drive, Manhasset, NY 11030 Phone: 516-562-4103 | |
Dr. Malcolm E Levine, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1201 Northern Blvd, Manhasset, NY 11030 Phone: 516-627-1221 Fax: 516-627-6857 | |
Dr. Angela C Kim, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Community Dr, Manhasset, NY 11030 Phone: 516-562-4280 Fax: 516-975-4994 | |
Dr. Roseann M Russo, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1165 Northern Blvd, Suite 300, Manhasset, NY 11030 Phone: 516-608-6820 Fax: 516-608-6821 | |
Dr. Zahava Farkas, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 444 Community Dr Ste 302, Manhasset, NY 11030 Phone: 516-387-6826 |